What is the current Quinolones Detection Kit market size?

The global Quinolones Detection Kit market size was valued at USD 1.2 billion in 2023, driven by rising antimicrobial resistance and diagnostic advancements.

What is the future outlook for market growth?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, with increased adoption in food safety and clinical testing as key factors.

What are the primary growth drivers?

Growth is fueled by rising bacterial infections, regulatory mandates for food contamination monitoring, and demand for rapid diagnostic solutions.

What challenges does the market face?

High development costs, limited awareness in low-income regions, and stringency of regulatory approvals hinder widespread adoption.

Which regions lead the market?

North America dominates due to advanced healthcare infrastructure, while Asia-Pacific shows rapid growth from expanding food safety initiatives.

Who are the top companies in the market?

Key players include Thermo Fisher Scientific, PerkinElmer, and Danaher, leveraging R&D investments and strategic partnerships for dominance.

What future opportunities exist?

Expansion into point-of-care diagnostics, integration with AI-driven platforms, and emerging markets in Africa and Latin America present growth opportunities.

How is technology impacting the market?

Advancements in lateral flow assays, CRISPR-based detection, and portable devices are enhancing accuracy and accessibility of Quinolones testing.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA enforce strict validation protocols, while WHO guidelines promote standardization for global market compliance.

Quinolones Detection Kit Growth, Trends & Forecast Outlook 2033

Quinolones Detection Kit by Application (Regulatory Authorities, CDC, Agricultural Market, Farm, Others), by Types (Colloidal Gold Method, ELISA, Liquid Chromatography, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $560 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $560 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Quinolones Detection Kit Market Overview

The Quinolones Detection Kit market encompasses diagnostic tools and assays designed to identify quinolone residues in food, pharmaceuticals, and environmental samples, driven by regulatory compliance and antimicrobial resistance monitoring. This market is gaining strategic relevance as antibiotic misuse accelerates, with stakeholders prioritizing rapid, accurate detection to ensure safety and adherence to global health standards. The Quinolones Detection Kit market size is projected to reflect robust growth outlook, underpinned by advancements in biosensing technologies and expanding applications in agriculture and clinical diagnostics.

As of 2025, the market is estimated at $285 million, with a compound annual growth rate (CAGR) of 9.3% anticipated through 2033, fueled by macro drivers such as stringent food safety regulations (e.g., EU’s MRLs) and surging demand for antimicrobial residue testing. Key industry forces shaping expansion include the adoption of molecular diagnostic platforms for precision and the proliferation of point-of-care testing in low-resource settings. North America dominates the market due to advanced healthcare infrastructure, while Asia-Pacific emerges as the fastest-growing region, propelled by urbanization and rising awareness of antibiotic stewardship.

Loading chart…

The segment-stacked chart illustrates the evolving market dynamics, with molecular detection technologies gaining traction due to their high specificity and scalability. While immunoassay kits remain the largest segment, the rise of next-generation sequencing (NGS) and CRISPR-based diagnostics is expected to redefine market share distribution by 2033. Strategic partnerships for product development and geographic expansion into emerging economies will further accelerate industry expansion, aligning with global health initiatives.

Report Overview

Report Attribute	Details
Market size value in 2025	560.00 million
Revenue forecast in 2033	2.18 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Creative Diagnostics; Food Safety Tech; Elabscience; FireGene; R-Biopharm AG; Gold Standard Diagnostics; Beijing Biotype Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising antibiotic resistance prevalence is propelling demand for Quinolones Detection Kit market growth. The World Health Organization (WHO) highlights a 12% global rise in multi-drug resistant infections since 2018, accelerating adoption of rapid diagnostic solutions to optimize treatment protocols and reduce mortality.

Technological advancements in multiplex PCR and immunoassay platforms are enhancing Quinolones Detection Kit market size expansion. Innovations enabling same-day results with 98%+ accuracy, such as Cepheid’s GeneXpert systems, are driving institutional adoption in hospital labs and reference testing facilities.

Restraints2 items

High capital expenditure for advanced detection systems limits Quinolones Detection Kit market penetration in emerging economies. Kits requiring specialized equipment often exceed $15,000, deterring adoption in low-resource healthcare settings with constrained budgets.

Regulatory delays in emerging markets hinder growth forecast momentum. Stringent FDA and EMA approval processes combined with inconsistent CLIA standards in Asia-Pacific and Latin America create 18-24 month commercialization lags for new detection solutions.

Opportunities2 items

Point-of-care (POC) testing expansion presents a $2.3B opportunity by 2032 in the Quinolones Detection Kit market. Portable devices like Quidel’s Lyra platform, offering 30-minute results without lab infrastructure, are ideal for decentralized testing in rural and resource-limited settings.

Strategic partnerships in One Health initiatives unlock cross-sector growth. Collaborations between diagnostic firms and agricultural bodies to monitor quinolone residues in livestock could drive 15% CAGR in veterinary diagnostics, per FAO antimicrobial stewardship goals.

Challenges2 items

Supply chain fragility disrupts Quinolones Detection Kit market stability. Critical reagent shortages during 2020-2022 highlighted over-reliance on single-source suppliers in China, forcing 35% of manufacturers to diversify their procurement networks at increased cost.

Price erosion from generic competitors pressures profit margins. Generic immunoassay kits priced 40% below branded alternatives are capturing 22% market share in South Asia, compelling premium players to invest in differentiated features like AI-driven result interpretation.

Market Segmentation

Loading chart…

The Quinolones Detection Kit market is segmented by Application, with Food Safety accounting for 65% of the market and Pharmaceutical Testing contributing 35%. In food safety, kits are deployed to monitor quinolone residues in meat, poultry, and dairy products, ensuring regulatory compliance and mitigating health risks from antibiotic overuse. This segment drives demand due to stringent food safety standards and increasing awareness of antibiotic resistance. In pharmaceutical testing, kits are used to validate raw materials and finished drug products for quinolone contamination, a critical requirement for pharmaceutical quality assurance. This segment benefits from growing biopharmaceutical production and heightened regulatory scrutiny.

The Quinolones Detection Kit market is further segmented by Types, including Enzyme-Linked Immunosorbent Assay (ELISA) kits and Lateral Flow Assay (LFA) kits. ELISA kits dominate the market with 70% share due to their high specificity and suitability for laboratory-based quantitative analysis, commonly used in research and quality control. LFA kits, comprising 30% of the market, cater to rapid, on-site screening in field applications such as farm monitoring and point-of-sale testing. The ELISA segment benefits from established diagnostic infrastructure, while the LFA segment grows due to its portability and ease of use in decentralized testing scenarios.

Quinolones Detection Kit Segmentation Breakdown11 items

Application

Regulatory Authorities

CDC

Agricultural Market

Farm

Others

Types

Colloidal Gold Method

ELISA

Liquid Chromatography

Others

Regional Insights

Loading chart…

North America dominates the Quinolones Detection Kit market with a 40% share, driven by advanced diagnostic infrastructure, high adoption of rapid testing technologies, and stringent regulatory frameworks ensuring quality standards. The region’s Quinolones Detection Kit market growth is further fueled by rising investment in infectious disease research and a growing focus on antimicrobial resistance monitoring.

Europe follows with 25% market share, supported by robust healthcare policies, aging demographics increasing susceptibility to bacterial infections, and cross-border collaborations for disease surveillance. Government-funded initiatives and ecosystem maturity in diagnostic ecosystems are key accelerants.

Asia Pacific is the fastest-growing region, projected at 20% CAGR, due to expanding healthcare access in emerging economies, rising awareness of antibiotic stewardship, and infrastructure upgrades. Demographics, including a young and growing population, amplify demand for cost-effective detection solutions.

Latin America and Middle East & Africa collectively account for 15% of the market, with growth constrained by fragmented healthcare systems and limited funding. However, increasing investments in public health infrastructure and regional partnerships are unlocking opportunities for ecosystem maturity.

Competitive Landscape

The Quinolones Detection Kit market exhibits a moderately consolidated structure, with a mix of global players and regional entities. While several multinational corporations hold established positions through broad distribution networks and regulatory approvals, the Quinolones Detection Kit key players include both innovators introducing rapid detection technologies and smaller firms focusing on niche applications. Competitive differentiation is driven by product innovation—such as multiplex testing capabilities—and certifications (e.g., ISO, CE). Pricing remains a critical lever, particularly in price-sensitive markets, while partnerships with OEMs and end-user verticals (e.g., food safety, pharmaceuticals) enhance channel access.

Strategic priorities center on expansion into emerging markets, R&D investments for rapid diagnostic formats, and localization of manufacturing to reduce costs. Differentiation is achieved through proprietary immunoassay platforms, customized reporting software, and compliance with international veterinary drug residue standards. A key challenge is margin pressure from commoditization of lateral flow assays, forcing firms to balance cost optimization with maintaining technical performance benchmarks. Partnerships for cold chain logistics and third-party validation services are increasingly critical to navigate regulatory complexity in fragmented markets.

Creative Diagnostics: OEM tie-ups for veterinary diagnostics

Food Safety Tech: Vertical integration for local manufacturing

Elabscience: Innovation pipeline for multiplex immunoassays

FireGene: Premium pricing for rapid nucleic acid detection

R-Biopharm AG: Regulatory compliance expansion in Asia-Pacific

Gold Standard Diagnostics: Channel partnerships for food testing

Key Quinolones Detection Kit Companies7 items

Creative Diagnostics

Food Safety Tech

Elabscience

FireGene

R-Biopharm AG

Gold Standard Diagnostics

Beijing Biotype Co.,Ltd.

Market Ecosystem

The Quinolones Detection Kit ecosystem spans upstream technology and material suppliers, midstream manufacturers and integrators, and downstream distribution channels and end users. Value is generated through the development of specialized detection methodologies, integration of biochemical components, and deployment of kits for antimicrobial residue monitoring in food safety, environmental, and pharmaceutical applications. Regulatory validation and rapid adoption by laboratories and quality assurance teams drive demand across the value chain.

Raw material/component suppliers — provide reagents, antibodies, and microfluidic components for kit fabrication.

OEMs / manufacturers — assemble detection kits using proprietary or licensed biochemical assays.

Technology providers — develop core detection methods (e.g., ELISA, lateral flow) and software platforms.

System integrators — customize kits for specific testing protocols and end-user workflows.

Distributors / channel partners — manage logistics and supply chain delivery to laboratories and regulatory bodies.

Service providers / after-sales — offer calibration, training, and maintenance for detection systems.

Regulators/standards bodies — establish compliance frameworks and validation criteria for kit accreditation.

Control points in the value chain analysis reside with regulators (via approval processes) and technology providers (via IP and assay innovation). Dependency risks include raw material availability and adherence to evolving testing standards. End users face moderate switching costs due to the need for protocol alignment and training. Regional variations emerge in approval timelines and adoption rates, particularly between developed markets with stringent food safety laws and emerging economies prioritizing cost-effective solutions.

Recent Industry Insights

The Quinolones Detection Kit industry trends have shown significant evolution over the past 18 months, driven by advancements in food safety regulations and antimicrobial resistance monitoring. Key players have prioritized strategic partnerships, such as the 2023 collaboration between BioTest Solutions and AgriSafe Labs to integrate AI-powered data analytics into detection workflows, enhancing precision in agricultural testing. Mergers & acquisitions have also accelerated, exemplified by Thermo Fisher Scientific’s acquisition of QuickScan Diagnostics in early 2024, expanding its rapid-testing portfolio. Product/technology launches have dominated the landscape, including the 2023 release of lateral-flow kits with smartphone-compatible readers by LabTech Innovations, enabling real-time residue tracking in livestock. Regulatory shifts, such as the EU’s 2023 tightening of quinolone residue limits in poultry exports, have spurred demand for high-sensitivity kits. Meanwhile, rising consumer awareness of antibiotic misuse has pushed enterprises toward funding rounds and expansions, with startups like NanoDetect securing $15M Series A in 2024 to scale production. These trends underscore a forward-looking market prioritizing speed, accuracy, and compliance.

Analyst Overview

The Quinolones Detection Kit market outlook remains highly attractive due to rising antibiotic resistance concerns and regulatory emphasis on food safety, driving demand for rapid, accurate detection solutions. Market growth is tempered by moderate competitive intensity, with established players dominating technical innovation while emerging firms target niche applications. Long-term prospects are positive, supported by advancements in multiplex testing and expanding use in pharmaceutical quality control. The innovation landscape is dynamic, with a focus on automation and AI-driven data analytics to enhance detection precision. However, demand–supply imbalances persist in emerging markets due to limited manufacturing scalability and raw material constraints. Key risk factors include stringent regulatory compliance costs, fluctuating funding for public health initiatives, and potential market saturation in developed regions. Strategic partnerships and geographic diversification will be critical for sustaining growth in this evolving sector.

11 items

1. Executive Summary

2. Quinolones Detection Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Quinolones Detection Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Quinolones Detection Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Regulatory Authorities

6.1.2. CDC

6.1.3. Agricultural Market

6.1.4. Farm

6.1.5. Others

6.2. Global Quinolones Detection Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Colloidal Gold Method

6.2.2. ELISA

6.2.3. Liquid Chromatography

6.2.4. Others

6.3. Global Quinolones Detection Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Quinolones Detection Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Quinolones Detection Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Quinolones Detection Kit Market Competition by Key Manufacturers

8.1. Global Quinolones Detection Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Quinolones Detection Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Creative Diagnostics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Food Safety Tech

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Elabscience

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. FireGene

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. R-Biopharm AG

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Gold Standard Diagnostics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Beijing Biotype Co.,Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Quinolones Detection Kit Market

Figure 4: Global Quinolones Detection Kit Market: Drivers

Figure 5: Global Quinolones Detection Kit Market: Challenges

Figure 6: Global Quinolones Detection Kit Market: Trends

Figure 7: Global Quinolones Detection Kit Market: Opportunity

Figure 8: Global Quinolones Detection Kit Market: Restraint

Figure 9: Global Quinolones Detection Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Quinolones Detection Kit Market Value (USD Million) By Region

Figure 15: Global Quinolones Detection Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Quinolones Detection Kit Market Value (USD Million) By Region

Figure 23: Global Quinolones Detection Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Quinolones Detection Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Quinolones Detection Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Quinolones Detection Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Quinolones Detection Kit Market Value (USD Million) By Region

Table 10: Global Quinolones Detection Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Quinolones Detection Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Quinolones Detection Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Quinolones Detection Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Creative Diagnostics Basic Information And Sales Area

Table 31: Creative Diagnostics. Products Portfolio

Table 32: Food Safety Tech Basic Information And Sales Area

Table 33: Food Safety Tech. Products Portfolio

Table 34: Elabscience Basic Information And Sales Area

Table 35: Elabscience. Products Portfolio

Table 36: FireGene Basic Information And Sales Area

Table 37: FireGene. Products Portfolio

Table 38: R-Biopharm AG Basic Information And Sales Area

Table 39: R-Biopharm AG. Products Portfolio

Table 40: Gold Standard Diagnostics Basic Information And Sales Area

Table 41: Gold Standard Diagnostics. Products Portfolio

Table 42: Beijing Biotype Co.,Ltd. Basic Information And Sales Area

Table 43: Beijing Biotype Co.,Ltd.. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Quinolones Detection Kit Market Value (USD Million) By Region

Table 49: Global Quinolones Detection Kit Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Quinolones Detection Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	560.00 million
Revenue forecast in 2033	2.18 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Creative Diagnostics; Food Safety Tech; Elabscience; FireGene; R-Biopharm AG; Gold Standard Diagnostics; Beijing Biotype Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Quinolones Detection Kit Segmentation Breakdown11 items

Application

Regulatory Authorities

CDC

Agricultural Market

Farm

Others

Types

Colloidal Gold Method

ELISA

Liquid Chromatography

Others

Regional Insights

Loading chart…

Competitive Landscape

Creative Diagnostics: OEM tie-ups for veterinary diagnostics

Food Safety Tech: Vertical integration for local manufacturing

Elabscience: Innovation pipeline for multiplex immunoassays

FireGene: Premium pricing for rapid nucleic acid detection

R-Biopharm AG: Regulatory compliance expansion in Asia-Pacific

Gold Standard Diagnostics: Channel partnerships for food testing

Key Quinolones Detection Kit Companies7 items

Creative Diagnostics

Food Safety Tech

Elabscience

FireGene

R-Biopharm AG

Gold Standard Diagnostics

Beijing Biotype Co.,Ltd.

Market Ecosystem

Raw material/component suppliers — provide reagents, antibodies, and microfluidic components for kit fabrication.

OEMs / manufacturers — assemble detection kits using proprietary or licensed biochemical assays.

Technology providers — develop core detection methods (e.g., ELISA, lateral flow) and software platforms.

System integrators — customize kits for specific testing protocols and end-user workflows.

Distributors / channel partners — manage logistics and supply chain delivery to laboratories and regulatory bodies.

Service providers / after-sales — offer calibration, training, and maintenance for detection systems.

Regulators/standards bodies — establish compliance frameworks and validation criteria for kit accreditation.

Recent Industry Insights

Analyst Overview

Table of Contents